Literature DB >> 35661061

XIAP as a multifaceted molecule in Cellular Signaling.

Mina Hanifeh1, Farangis Ataei2.   

Abstract

XIAP, X-linked inhibitor of apoptosis protein, is a member of the inhibitor of apoptosis protein (IAP) family known for its important conserved inhibitory effect on caspase activity. Since the introduction of XIAP almost three decades ago, numerous experimental studies have been performed for a wide range of cellular pathways and mechanisms. In this perspective, we summarize key trends of XIAP as an important regulator of cellular signaling. Experimental research indicates that XIAP as a key molecule of cell death not only suppress caspases and apoptosis, but also regulates inflammatory signaling, mitogenic kinase signaling, cell proliferation as well as cell invasion and metastasis. In this review, we provide basic knowledge of the roles of XIAP, explain its role in necroptosis, anoikis, autophagy and neuronal differentiation. XIAP is involved in regulating intracellular ROS production and copper homeostasis which this review focuses on. A different face of XIAP in response to DNA damage and chronic ER stress is also discussed.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cell death; ER stress; Multifunction; ROS production; XIAP

Mesh:

Substances:

Year:  2022        PMID: 35661061     DOI: 10.1007/s10495-022-01734-z

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   5.561


  96 in total

1.  X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes.

Authors:  Y Suzuki; Y Nakabayashi; K Nakata; J C Reed; R Takahashi
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

Review 2.  IAP family proteins--suppressors of apoptosis.

Authors:  Q L Deveraux; J C Reed
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

Review 3.  Caspases: the proteases of the apoptotic pathway.

Authors:  G Nuñez; M A Benedict; Y Hu; N Inohara
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

Review 4.  Advances in apoptosis research.

Authors:  M E Peter; A E Heufelder; M O Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Effects of doxorubicin and docetaxel on susceptibility to apoptosis in high expression level of survivin in HEK and HEK-S cell lines as in vitro models.

Authors:  Kayhan Mehdizadeh; Farangis Ataei; Saman Hosseinkhani
Journal:  Biochem Biophys Res Commun       Date:  2020-08-20       Impact factor: 3.575

6.  IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.

Authors:  Q L Deveraux; N Roy; H R Stennicke; T Van Arsdale; Q Zhou; S M Srinivasula; E S Alnemri; G S Salvesen; J C Reed
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

7.  Insufficient Apaf-1 expression in early stages of neural differentiation of human embryonic stem cells might protect them from apoptosis.

Authors:  Somayeh Karimzadeh; Saman Hosseinkhani; Ali Fathi; Farangis Ataei; Hossein Baharvand
Journal:  Eur J Cell Biol       Date:  2018-02-01       Impact factor: 4.492

8.  Efficient Stable Cell Line Generation of Survivin as an In Vitro Model for Specific Functional Analysis in Apoptosis and Drug Screening.

Authors:  Rashid Houshdarpour; Farangis Ataei; Saman Hosseinkhani
Journal:  Mol Biotechnol       Date:  2021-03-25       Impact factor: 2.860

9.  Upregulation of apoptotic protease activating factor-1 expression correlates with anti-tumor effect of taxane drug.

Authors:  Meysam Bakhshoudeh; Kayhan Mehdizadeh; Saman Hosseinkhani; Farangis Ataei
Journal:  Med Oncol       Date:  2021-06-28       Impact factor: 3.064

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.